Cargando…

SAT-282 Outcomes in Children Treated with Growth Hormone for Prader-Willi Syndrome: Data from the Answer® Program and Nordinet® International Outcome Study (IOS)

Background: The American Norditropin® Studies: Web-Enabled Research (ANSWER) Program and the NordiNet® International Outcome Study (NordiNet® IOS) are complementary, large-scale, non-interventional studies designed to gather long-term data on the effectiveness and safety of Norditropin® (somatropin)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Angulo, Moris, Abuzzahab, Mary, Pietropoli, Alberto, Ostrow, Vlady, Tauber, Maithe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Pediatric Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551764/ http://dx.doi.org/10.1210/js.2019-SAT-282

Ejemplares similares

Outcomes in children treated with growth hormone for Prader-Willi syndrome: data from the ANSWER Program® and NordiNet® International Outcome Study
por: Angulo, Moris, et al.
Publicado: (2020)

Treatment of Children With GH in the United States and Europe: Long-Term Follow-Up From NordiNet(®) IOS and ANSWER Program
por: Sävendahl, Lars, et al.
Publicado: (2019)

Effectiveness and Safety of Early Growth Hormone Treatment in Children Born Small for Gestational Age: Long-Term Data From NordiNet® International Outcome Study (IOS) and ANSWER Program
por: Juul, Anders, et al.
Publicado: (2021)

LBMON197 Predictors Of Response To Growth Hormone Treatment In Pediatric Growth Disorders: Analysis From The Answer Program And Nordinet® IOS
por: Ross, Judith L, et al.
Publicado: (2022)

Approach to the Patient With Prader–Willi Syndrome
por: Höybye, Charlotte, et al.
Publicado: (2022)

Liraglutide for Weight Management in Children and Adolescents With Prader–Willi Syndrome and Obesity
por: Diene, Gwenaëlle, et al.
Publicado: (2022)

Early GH Treatment Is Effective and Well Tolerated in Children With Turner Syndrome: NordiNet(®) IOS and Answer Program
por: Backeljauw, Philippe, et al.
Publicado: (2023)

Long-Term Safety of Growth Hormone Treatment in Childhood: Two Large Observational Studies: NordiNet IOS and ANSWER
por: Sävendahl, Lars, et al.
Publicado: (2021)

Food socialization of children with Prader-Willi syndrome: an interdisciplinary problematization
por: Rochedy, Amandine, et al.
Publicado: (2023)

French database of children and adolescents with Prader-Willi syndrome
por: Molinas, Catherine, et al.
Publicado: (2008)

Prader-Willi syndrome: A primer for clinicians
por: Cataletto, Mary, et al.
Publicado: (2011)

SAT-380 Screening for Central Adrenal Insufficiency in Children with Prader-Willi Syndrome (PWS) with Single Collection Of ACTH and Cortisol Levels
por: Angulo, Moris, et al.
Publicado: (2019)

Behavioral profile of adults with Prader-Willi syndrome: correlations with individual and environmental variables
por: Jauregi, Joseba, et al.
Publicado: (2013)

Abstract 2: Effectiveness and safety of early growth hormone treatment in children born small for gestational age: Long-term data from NordiNet® International Outcome Study (IOS) and ANSWER program
por: Ranjan, K M, et al.
Publicado: (2022)

Early diagnosis and care is achieved but should be improved in infants with Prader-Willi syndrome
por: Bar, Céline, et al.
Publicado: (2017)

The transition from pediatric to adult care in individuals with Prader-Willi syndrome
por: Poitou, Christine, et al.
Publicado: (2022)

A study of voice and non-voice processing in Prader-Willi syndrome
por: Strenilkov, Kuzma, et al.
Publicado: (2020)

Case report: Prader–Willi syndrome and inflammatory arthritis—An important consideration
por: Marelli, Luca, et al.
Publicado: (2023)

Physical Activity in Patients with Prader-Willi Syndrome—A Systematic Review of Observational and Interventional Studies
por: Bellicha, Alice, et al.
Publicado: (2021)

SAT-092 Positive Effect of an Early Start of Growth Hormone Therapy on Auxology and Metabolic Parameters in Children with Prader Willi Syndrome
por: Gohlke, Bettina, et al.
Publicado: (2020)

Effects of the COVID-19 pandemic and lockdown on the mental and physical health of adults with Prader-Willi syndrome
por: Mosbah, Helena, et al.
Publicado: (2021)

Face processing and exploration of social signals in Prader-Willi syndrome: a genetic signature
por: Debladis, Jimmy, et al.
Publicado: (2019)

Is ghrelin a biomarker of early-onset scoliosis in children with Prader–Willi syndrome?
por: Pacoricona Alfaro, Dibia Liz, et al.
Publicado: (2021)

Equivocal expression of emotions in children with Prader-Willi syndrome: what are the consequences for emotional abilities and social adjustment?
por: Famelart, Nawelle, et al.
Publicado: (2020)

Case Report: Clinical Analysis of Seven Neonates With Prader-Willi Syndrome and Review of the Literature
por: Hu, Yu, et al.
Publicado: (2021)

The Hyperphagia Questionnaire: Insights From a Multicentric Validation Study in Individuals With Prader Willi Syndrome
por: Licenziati, Maria Rosaria, et al.
Publicado: (2022)

Evaluation of Methods That Estimate Glomerular Filtration Rate in Patients With Prader-Willi Syndrome
por: Ko, Paul Jihoon, et al.
Publicado: (2021)

Height outcomes in children with growth hormone deficiency and idiopathic short stature treated concomitantly with growth hormone and aromatase inhibitor therapy: data from the ANSWER program
por: Miller, Bradley S., et al.
Publicado: (2020)

Long-term Effectiveness and Safety of GH Replacement Therapy in Adults ≥60 Years: Data From NordiNet® IOS and ANSWER
por: Biller, Beverly M K, et al.
Publicado: (2023)

Hyponatremia in Children and Adults with Prader–Willi Syndrome: A Survey Involving Seven Countries
por: Coupaye, Muriel, et al.
Publicado: (2021)

High unacylated ghrelin levels support the concept of anorexia in infants with prader-willi syndrome
por: Beauloye, Veronique, et al.
Publicado: (2016)

SNORD116 and growth hormone therapy impact IGFBP7 in Prader–Willi syndrome
por: Eddiry, Sanaa, et al.
Publicado: (2021)

Pregnancy outcomes in women receiving growth hormone replacement therapy enrolled in the NordiNet® International Outcome Study (IOS) and the American Norditropin® Studies: Web-Enabled Research (ANSWER) Program
por: Biller, Beverly M. K., et al.
Publicado: (2021)

The RDoC approach for translational psychiatry: Could a genetic disorder with psychiatric symptoms help fill the matrix? the example of Prader–Willi syndrome
por: Salles, Juliette, et al.
Publicado: (2020)

ODP383 Clinical Presentation and Management of Diabetes Mellitus in Youth with Prader-Willi Syndrome
por: Paprocki, Emily, et al.
Publicado: (2022)

SAT-100 Trial-in-Progress: ZEPHYR, a Pivotal Phase 2b/3 Randomized, Placebo-Controlled Study of Livoletide, a Novel Unacylated Ghrelin Analog, for the Treatment of Hyperphagia and Food-Related Behaviors in Patients with Prader-Willi Syndrome
por: Allas, Soraya, et al.
Publicado: (2019)

CORRIGENDUM for “Treatment of Children With GH in the United States and Europe: Long-Term Follow-Up From NordiNet® IOS and ANSWER Program”
Publicado: (2020)

Three Siblings with Prader-Willi Syndrome: Brief Review of Sleep and Prader-Willi Syndrome
por: Bingeliene, Arina, et al.
Publicado: (2015)

Diazoxide Choline Extended-Release Tablet in People With Prader-Willi Syndrome: A Double-Blind, Placebo-Controlled Trial
por: Miller, Jennifer L, et al.
Publicado: (2023)

Effect of topiramate on eating behaviours in Prader-Willi syndrome: TOPRADER double-blind randomised placebo-controlled study
por: Consoli, Angèle, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gh1ecbrdo29air3e308kq9c3n4